Finance

Lists
LBRX:NASDAQ
LB Pharmaceuticals Inc
$46.23
-3.23%
(-1.55) 1D
$46.23
0.00% (0.00)
After hours
Closed: Aug 17, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LBRX...
Open
$47.10
High
$47.96
Low
$46.11
Mkt. cap
1.49B
Avg. vol.
352.49K
Volume
0.00
52-wk high
$49.14
52-wk low
$13.40
EPS
-$1.49
Shares outstanding
32.26M
No. of employees
49
Open
$47.10
High
$47.96
Low
$46.11
Mkt. cap
1.49B
Avg. vol.
352.49K
Volume
0.00
52-wk high
$49.14
52-wk low
$13.40
EPS
-$1.49
Shares outstanding
32.26M
No. of employees
49
News stories
From web sources and news partners
About LB Pharmaceuticals Inc
CEO-
Employees49
Founded2015
Headquarters-
SectorPharmaceutical industry
Websitelbpharma.us
Analyst ratings
Based on 8 analysts giving stock ratings to LBRX in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for LBRX in the last 3 months.
Highest
Current $46.23
$78.00 (+68.72%)
Average
$49.25 (+6.53%)
Lowest
$37.00 (-19.97%)
Analyst
Recommendation
Action
Price target
Projected
Date
Paul Matteis
Stifel Nicolaus
Buy
Maintained
$53.00
+14.6%
08/13/2026
Adam Vogel
Craig-Hallum
Buy
Maintained
$45.00
-2.7%
08/12/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$78.00
+68.7%
08/03/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$45.00
-2.7%
08/03/2026
Unknown Analyst
BMO Capital
Buy
Initiated
$46.00
-0.5%
07/21/2026
Malcolm Hoffman
BMO Capital
Buy
Initiated
$46.00
-0.5%
07/21/2026
Rudy Li
Wolfe Research
Buy
Initiated
$45.00
-2.7%
07/07/2026
Kaveri Pohlman
Clear Street
Buy
Initiated
$45.00
-2.7%
05/26/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Reiterated
$37.00
-20%
05/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.42M
7.98M
14.54M
43.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.83M
4.99M
7.46M
8.97M
Operating expense
5.25M
12.97M
22.00M
52.02M
Total operating expenses
5.25M
12.97M
22.00M
52.02M
Operating income
-5.25M
-12.97M
-22.00M
-52.02M
Other non operating income
983.00K
-401.00K
200.00K
-662.00K
EBT including unusual items
-3.56M
-11.47M
-19.05M
-51.60M
EBT excluding unusual items
-3.56M
-10.57M
-18.95M
-49.70M
Income tax expense
-
1.00K
-
-
Effective tax rate
-
-0.01%
-
-
Other operating expenses
-
-
-
-
Net income
-3.56M
-11.47M
-19.05M
-51.60M
Net profit margin
-
-
-
-
Earnings per share
-0.61
-0.45
-0.67
-1.71
Interest and investment income
707.00K
2.80M
2.85M
2.97M
Interest expense
-
-
-
-
Net interest expenses
707.00K
2.80M
2.85M
2.97M
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.16M
-12.88M
-21.92M
-51.92M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps